Xvivo Perfusion

274,40 SEK

-0,72%

Mindre end 1K følgere

XVIVO

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Værdiansættelse

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Xvivo Perfusion

P/E

Medianen 2019-2025

EV/S

Medianen 2019-2024

EV/EBIT

Medianen 2019-2024

P/B

Medianen 2019-2025

 
2019202020212022202320242025
Aktiekurs (SEK)170,00314,00278,50183,00329,50489,00186,60
Aktier26,527,028,729,831,531,531,5
Markedsværdi4.502,38.482,17.998,25.459,210.379,115.403,25.877,8
Enterprise value4.347,98.197,67.605,35.222,79.864,415.021,8-
EV/S19,745,629,412,616,518,3-
EV/EBITDA151,0neg.552,7107,5122,585,3-
EV/EBIT1.103,5neg.neg.814,82.354,3170,0-
P/E912,0neg.981,3295,2107,389,4233,2
P/B7,808,416,223,825,347,142,78
P/S20,447,231,013,117,418,77,2
Udbytteprocent0,0 %0,0 %0,0 %0,0 %0,0 %0,0 %0,0 %
Equity ratio91,0 %87,7 %83,3 %82,5 %89,2 %89,8 %89,0 %
Gearing ratio1,0 %6,9 %0,4 %0,7 %1,6 %1,6 %5,9 %